Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
ABSTRACTNucleic acid vaccines are designed based on genetic sequences (DNA or mRNA) of a target antigen to be expressed in vivo to drive a host immune response. In response to the COVID-19 pandemic, mRNA and DNA vaccines based on the SARS-CoV-2 Spike antigen were developed. Surprisingly, head-to-hea...
Main Authors: | Viviane M. Andrade, Igor Maricic, Richa Kalia, Lauren Jachimowicz, Olivia Bedoya, Daniel W. Kulp, Laurent Humeau, Trevor R. F. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2281733 |
Similar Items
-
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
by: Nicole V. Tolan, et al.
Published: (2022-04-01) -
Protective efficacy of a universal influenza mRNA vaccine against the challenge of H1 and H5 influenza A viruses in mice
by: Yulei Li, et al.
Published: (2023-09-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
by: Dylan Kairuz, et al.
Published: (2022-10-01) -
Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
by: Szu-Ting Huang, et al.
Published: (2023-11-01) -
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response
by: Elena P. Mazunina, et al.
Published: (2024-04-01)